FDA Clears IND for CS2009 Trispecific Antibody Trial
SUZHOU, China, Feb. 15, 2026 — CStone Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Investigational...
solid tumors
Advertisement
FDA Clears PRD-101 Nano Cancer Drug for Phase 1
SEONGNAM, South Korea, Feb. 6, 2026 — PharmaResearch Co., Ltd. announced that the U.S. Food and Drug Administration (FDA)...
Janux and BMS Partner on Tumor-Activated Cancer Therapy
SAN DIEGO, January 22, 2026 — Janux Therapeutics announced a collaboration and exclusive worldwide license agreement with Bristol Myers...
FDA Clears Allogeneic CAR-T MT027 for Phase II Glioblastoma
December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...
PRAME Cell Therapy Shows Strong Early Responses in Phase 1 Study
HOUSTON, Texas & TÜBINGEN, Germany — December 11, 2025 — Immatics N.V. announced compelling Phase 1a dose-escalation data for...
Advertisements
Rondo Therapeutics Begins Phase I Trial of RNDO-564 in Advanced Tumors
Dateline – San Francisco, CA – December 2025: Rondo Therapeutics has dosed the first patient in its Phase I...
Verismo Therapeutics Unveils Promising CAR T Advances for Solid Tumors at SITC 2025
Philadelphia, November 10, 2025 — Verismo Therapeutics, a clinical-stage biotechnology company pioneering KIR-CAR T cell therapies, presented compelling preclinical...
Abalos Therapeutics’ ABX-001 Validated in Cell Reports Medicine
October 14, 2025 | Düsseldorf, Germany — Abalos Therapeutics announced the publication of preclinical proof-of-concept data in Cell Reports...
MaxCyte Partners with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
ROCKVILLE, Md., Oct. 6, 2025 — MaxCyte, Inc. announced a Strategic Platform License (SPL) agreement with Moonlight Bio to...
Verismo Partners with Miltenyi Biotec to Advance KIR-CAR Clinical Programs
Philadelphia, September 25, 2025 – Verismo Therapeutics, a clinical-stage biotechnology company specializing in KIR-CAR T cell therapies, has announced...
Advertisement
